SCHEMBL24601494

SCHEMBL24601494

c1ccc(-c2ccc(-c3ccc4c5c6c7ccccc7n7c8cc(-c9ccc(-c%10ccccc%10)cc9-c9ccccc9)ccc8c(c8c9ccccc9n(c4c3)c85)c67)c(-c3ccccc3)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.35
MEN1 O00255 2/20 0.35
MAPT P10636 2/20 0.35
KMT2A Q03164 2/20 0.35
APAF1 O14727 1/20 0.35
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
THRB P10828 1/20 0.35
XBP1 P17861 1/20 0.35
PTBP1 P26599 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
GALK1 P51570 1/20 0.35
BLM P54132 1/20 0.35
SMAD3 P84022 1/20 0.35
ATM Q13315 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24601426 1.00 MAOB (0.35) MAOBMEN1MAPTKMT2AAPAF1
SCHEMBL24601508 0.91 TSPO (0.37) MAOBMEN1MAPTKMT2AAPAF1
SCHEMBL22178719 0.91 TSPO (0.37) MAOBMEN1MAPTKMT2AAPAF1
SCHEMBL22178594 0.91 HSD17B10 (0.37) MAOBMEN1MAPTKMT2AHSD17B10
SCHEMBL22178597 0.89 MAOB (0.41) MAOBHSD17B10RXRARXRBLIMK1
SCHEMBL24601437 0.86 MAOB (0.39) MAOBL3MBTL1HSD17B10RXRARXRB
SCHEMBL24601799 0.86 HSD17B10 (0.34) MAOBMEN1MAPTKMT2ALMNA
SCHEMBL24601466 0.84 MAOB (0.44) MAOBMEN1MAPTKMT2ALMNA
SCHEMBL24601497 0.84 HSD17B10 (0.35) MAOBMEN1MAPTKMT2ALMNA
SCHEMBL26026961 0.83 MEN1 (0.33) MAOBMEN1MAPTKMT2AAPAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220213113-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213113-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES NCL, NOC2L, NOLC1 MAOB 2002/4885MEN1 1635/4885MAPT 1370/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.